Skip to content

Why single-cell technologies are vital for Endometriosis research webinar

Why single-cell technologies are vital for Endometriosis research


Learn why single-cell technologies are vital for Endometriosis research by watching our webinar

Endometriosis is a debilitating disease that affects 10% of women and girls of reproductive age. There is no cure, no certain cause and no non-invasive method of diagnosing the disease, leading to a reduced quality of life for the patients and a significant socio-economic burden. Join us on our webinar on why single-cell technologies are vital for endometriosis research.

Prof. Dr Michael D. Mueller is an expert in endometriosis and women’s health. The complexity of this disease requires a novel research approach by single-cell analysis. Therefore, Prof. Dr. med. Müller started collaborating with Scailyte AG, the specialist in single-cell analysis. In a joint project, they strive to develop a non-invasive diagnosis method, and potentially a prognostic method to reduce the suffering of endometriosis patients. Prof. Mueller is a renowned gynaecologist and gynaecological oncologist, and managing director of the Women’s Health Clinic at the University Hospital of Bern (Inselspital). He is the founding member and current president of the working group for Endoscopic Gynecology.

Join this webinar with Prof. Mueller, in cooperation with Scailyte, to learn more about “Why single-cell technologies are vital for Endometriosis research.”

Watch the webinar here: https://youtu.be/XPmhGRy-1AY

 

 

About Scailyte

Scailyte AG is a data-driven biomarker discovery company, founded in Luzern, Switzerland in 2017. The ETH Spin-off is using cutting edge technologies within the single-cell space and a proprietary biomarker discovery platform to develop clinical diagnostic applications in oncology and women’s health. Scailyte is ranked among the Top100 Swiss Startups since 2019 and has won the MassChallenge Switzerland in 2018. www.scailyte.com
ScailyteTM and ScaiVisionTM are registered trademarks proprietary to Scailyte AG.

Recent News

PAPER: Mapping single-cell data - Nature Biotech

Large single-cell atlases are now routinely generated to serve as references for the analysis of sma

Read more

Recent News

Scailyte Closes Financing Round and Onboards Top Biotech Leaders

Scailyte has successfully finished the first closing of their series A. Two new investors joined the

Read more

Recent News

Scailyte Quarterly Update December 2021

December 2021 Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

Recent News

VACANCY: Regulatory Affairs / Quality Management Specialist

We are currently developing a first-in-class in vitro diagnostic tool for Endometriosis aiming at cu

Read more

Recent News

Why single-cell technologies are vital for Endometriosis research webinar

Prof. Dr Michael D. Mueller is an expert in endometriosis and women’s health. The complexity of th

Read more

Recent News

Single-Cell Discovery Grant in Oncology and Immunology

Open grant call of up to 100K Euro aimed at addressing unmet clinical needs in Oncology and Immunolo

Read more

Recent News

Scailyte and Lexogen create a joint biomarker discovery workflow

Scailyte, a single-cell biomarker discovery company and Lexogen, a leader in RNA sequencing solution

Read more

Recent News

Scailyte Quarterly Update June 2021

June 2021 Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

Recent News

01 /04

PAPER: Mapping single-cell data - Nature Biotech

Large single-cell atlases are now routinely generated to serve as references for the analysis of sma

Read more

Scailyte Closes Financing Round and Onboards Top Biotech Leaders

Scailyte has successfully finished the first closing of their series A. Two new investors joined the

Read more

Recent News

02 /04

Scailyte Quarterly Update December 2021

December 2021 Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

VACANCY: Regulatory Affairs / Quality Management Specialist

We are currently developing a first-in-class in vitro diagnostic tool for Endometriosis aiming at cu

Read more

Recent News

03 /04

Why single-cell technologies are vital for Endometriosis research webinar

Prof. Dr Michael D. Mueller is an expert in endometriosis and women’s health. The complexity of th

Read more

Single-Cell Discovery Grant in Oncology and Immunology

Open grant call of up to 100K Euro aimed at addressing unmet clinical needs in Oncology and Immunolo

Read more

Recent News

04 /04

Scailyte and Lexogen create a joint biomarker discovery workflow

Scailyte, a single-cell biomarker discovery company and Lexogen, a leader in RNA sequencing solution

Read more

Scailyte Quarterly Update June 2021

June 2021 Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

Recent News